After chemotherapy, patients with testicular germ cell tumors may experience a decrease in bone mineral density.
Controversy about the effects of subclinical thyroid dysfunction and bone health are further clouded by conflicting study results.
Risk for heart failure appeared to be increased with elevated parathyroid hormone levels.
Subclinical thyroid dysfunction may increase risk for fractures.
Four-year intervention linked to slight, but significant increase in bone loss in men, but not women.
WHO criteria better than National Osteoporosis Foundation criteria for identifying men who would benefit from drug treatment.